Smith, Moore & Co’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$237K Sell
871
-67
-7% -$19.2K 0.02% 501
2025
Q4
$270K Sell
938
-51
-5% -$14.2K 0.02% 440
2025
Q3
$257K Buy
989
+75
+8% +$18.8K 0.02% 443
2025
Q2
$227K Sell
914
-24
-3% -$5.93K 0.02% 458
2025
Q1
$248K Sell
938
-16
-2% -$4.26K 0.02% 415
2024
Q4
$242K Sell
954
-21
-2% -$5.66K 0.02% 415
2024
Q3
$275K Sell
975
-33
-3% -$9.17K 0.03% 375
2024
Q2
$268K Hold
1,008
0.03% 368
2024
Q1
$273K Sell
1,008
-54
-5% -$14.2K 0.03% 360
2023
Q4
$266K Buy
1,062
+38
+4% +$9K 0.03% 347
2023
Q3
$241K Hold
1,024
0.03% 335
2023
Q2
$251K Buy
1,024
+131
+15% +$31.9K 0.03% 341
2023
Q1
$213K Buy
+893
New +$215K 0.03% 356

Other funds holding VHT

Smith, Moore & Co's VHT Position: Q1 2026 in Review

Smith, Moore & Co reduced its Vanguard Health Care ETF (VHT) stake by 7.1% in Q1 2026, selling an estimated $19.2K and leaving 871 shares worth $237K. The position accounts for 0.02% of the portfolio, ranked #501.

Smith, Moore & Co first reported a position in VHT in Q1 2023 and has held it in 13 quarters since. The position peaked at $275K in Q3 2024. 1,085 funds tracked by Wall St. Rank hold VHT as of Q1 2026.

  • Smith, Moore & Co held 871 shares of Vanguard Health Care ETF worth $237K as of Q1 2026.
  • Smith, Moore & Co sold 67 Vanguard Health Care ETF shares in Q1 2026, an estimated $19.2K.
  • Vanguard Health Care ETF made up 0.02% of Smith, Moore & Co's portfolio in Q1 2026, its #501 holding.
  • Smith, Moore & Co first reported a position in Vanguard Health Care ETF in Q1 2023 and has held it in 13 quarters since.
  • Smith, Moore & Co's Vanguard Health Care ETF position peaked at $275K in Q3 2024.
  • 1,085 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q1 2026.

Based on Smith, Moore & Co's 13F filing for Q1 2026, filed 5 May 2026.